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Abstract
Helicobacter pylori infection is associated with chronic gastritis, peptic ulcer, gastric adenocarcinoma, and mucosa-associated lymphoid
tissue lymphoma. Some reports also suggest that it causes extragastric disease, including hepatitis. In this study, the pathological changes
in the liver and gall bladder in H. pylori-colonized C57BL/6 mice were investigated. Twenty mice were inoculated orally with H. pylori
strain SS1, and ten controls were injected with phosphate-buffered saline. Gastric colonization with H. pylori was assessed at 2 months
after inoculation. Mice were examined at 8 months by histopathology, culture for H. pylori, and PCR for speciﬁc H. pylori genes. All
C57BL/6 mice infected with H. pylori for 8 months developed severe gastric mucosal inﬂammation. Three mice showed mild-to-moder-
ate mutifocal hepatitis. The gall bladder mucosa of one H. pylori-infected mouse showed thickening of the mucous membrane with mild
submucosal lymphocytic inﬁltration. H. pylori was observed morphologically in four liver specimens and six gall bladders from infected
mice by immunohistochemistry. Speciﬁc H. pylori genes were also detected in six liver samples from infected mice, six samples of bile,
and two blood samples by nested PCR. Thus, H. pylori inoculated orally may reach the hepatobiliary system and cause inﬂammation as
an independent aetiological factor. The pathway to the liver may be via the blood or the biliary system.
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Introduction
During the past few years, infections due to Helicobacter spp.
have been reported to be associated with liver disease in
some animal species. Examples are Helicobacter canis in dogs,
Helicobacter pullorum in poultry, and Helicobacter hepaticus
and Helicobacter bilis in mice. It is of note that H. hepaticus
infection has been found to increase markedly the risk of
hepatic carcinoma, in particular in inbred strains of mice [1].
This type of murine model has proved useful in elucidating
the molecular mechanism of hepatic cancer associated with
Helicobacter infection [2]. The human gastric pathogen
Helicobacter pylori, which causes a persistent infection, is
considered to be a type I carcinogen because of its role in
the development of gastric carcinoma and gastric mucosa-
associated lymphoid tissue lymphoma [3]. It has been
suggested that in humans, as in animals, Helicobacter spp. may
also colonize the liver and induce chronic hepatic diseases,
especially hepatocellular carcinoma (HCC).
Recent studies have shown that cells or fragments of
Helicobacter spp. may be found in the livers of patients with pri-
mary sclerosing cholangitis and also those with primary biliary
cirrhosis [4,5]. Several separate research groups have
reported that DNA of Helicobacter spp. was present in liver tis-
sue from patients with primary HCC [6–8]. DNA sequencing
showed that the Helicobacter spp. involved were closely related
to H. pylori. De Magalha˜es Queiroz et al. [9] reported the cul-
ture of H. pylori from one patient with Wilson’s disease with
cirrhosis and cholestasis. These reports suggested that
H. pylori may play an important role in the development of he-
patobiliary diseases in humans. In our previous study, we found
that 60% (nine of 15) of the liver specimens from patients with
HCC were positive for the 16S rRNA gene of Helicobacter spp.
Sequence analysis and comparison showed that these Helicob-
acter spp. were closely related to H. pylori. Immunohistochemi-
cal staining also showed evidence of H. pylori [10,11].
Although H. pylori has been considered to be associated
with hepatobiliary diseases in humans, there are no detailed
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studies of the pathological changes in the hepatobiliary
system in H. pylori-infected animal models. In the present
study, we examined the changes in the liver and gall bladder
in H. pylori-colonized C57BL/6 mice.
Materials and Methods
Bacterial strains
H. pylori strain SS1 (a cagA-positive, vacA s2-m2 strain) was
grown on GAB-Camp agar consisting of 10% (v/v) sterile sheep
blood and Skirrow’s supplement (10 lg/mL vancomycin, 5 lg/
mL trimethoprim lactate, 2500 IU/L polymyxin B, and 5 lg/mL
amphotericin B). Plates were incubated for 48 h at 37C under
micro-aerophilic conditions [12]. The bacteria were harvested
in phosphate-buffered saline (PBS), visualized by Gram stain
and phase microscopy for purity, morphology, and motility,
and tested biochemically for urease, catalase and oxidase acitiv-
ity. The cells were centrifuged at 3000 g for 10 min, and resus-
pended in PBS at a ﬁnal concentration of 1 · 109 CFU/mL.
Animals
Conventional C57BL/6 male mice, 6–8 weeks old, were
housed in micro-isolator caging, and fed with pelleted rodent
chow and water ad libitum for the duration of the experiment.
Twenty C57BL/6 mice were inoculated orally three times at
2-day intervals with 0.5 mL of PBS containing 5 · 108 CFU of
H. pylori. Ten age-matched and sex-matched C57BL/6 mice
were used as control animals, and were inoculated orally with
PBS alone. Gastric colonization with H. pylori was assessed at
2 months and 8 months post-inoculation. Necropsy for histo-
pathology and bacterial isolation was performed at 8 months.
Bacterial isolation
Mucosal scrapings of gastric antrum and body were obtained
aseptically at necropsy, and were rinsed in PBS, smeared
directly on GAB-Camp agar, and incubated at 37C under
micro-aerophilic conditions. Samples of blood, bile and liver
were also collected aseptically at necropsy and cultured. Blood
obtained by cardiac puncture and bile were inoculated directly
onto blood agar plates. The liver tissues were ground in sterile
tissue grinders and were applied directly to GAB-Camp agar
plates. Plates were maintained for 10 days before a result
of no growth was recorded. The presence of H. pylori on the
culture plates was conﬁrmed by colony morphology, urease,
catalase and oxidase reactions, Gram staining, and PCR.
Histopathology and immunohistochemistry
Murine stomach, gall bladder and liver tissues were ﬁxed
in neutral buffered 10% formalin, embedded in parafﬁn,
sectioned at 4 lm, and stained with haematoxylin and eosin.
Colonization by H. pylori was also conﬁrmed by immuno-
staining with anti-H. pylori antibody (DAKO) and carbol
fuchsin staining [13].
DNA extraction
DNA was extracted from gastric mucosa, liver tissue and gall
bladder using a fast method. Tissue (50 mg) was homoge-
nized and centrifuged at 8000 g for 10 min. The DNA was
extracted as previously described [10].
To extract bacterial DNA from serum and bile, 250 lL of
ﬂuid was mixed with 250 lL of extraction buffer [22], and
incubated at 37C for 2 h; routine phenol–chloroform
extraction and ethanol precipitation were then performed.
PCR ampliﬁcation
Samples from hepatic tissue, blood and bile were ampliﬁed by
nested PCR for the H. pylori-speciﬁc 16S rRNA gene. The two
pairs of primers ampliﬁed a product of approximately 1020 bp.
The other six pairs of speciﬁc primers were used to look for
the 26-kDa, vacA and cagA genes of H. pylori. Table 1 shows the
nucleotide sequences of the primers used, the PCR conditions,
and the size of the ampliﬁed fragments. Samples from the gas-
tric mucosa were ampliﬁed only by outer primers of the above
four genes. The ampliﬁed products were analysed with 1.5%
(w/v) agarose gel, which was stained with ethidium bromide
and observed under short-wavelength ultraviolet light.
Sequencing and sequence analysis
The amplicons of the Helicobacter 16S rRNA gene were puri-
ﬁed using an agarose gel DNA extraction kit (Roche).
Sequence analysis was performed with an Applied Biosystems
DNA Sequencer. Sequence comparison was carried out using
the BLAST program and the GenBank databases.
Statistical analyses
To compare the occurrence of Helicobacter genes in the two
groups, the chi-square test was used. Signiﬁcance was
assigned to values of p <0.05.
Results
Clinical and gross ﬁndings
Two mice died at week 2 after infection. The experiment
was continued with the remaining 18 mice. All mice inocu-
lated orally with H. pylori became slightly to moderately
debilitated and emaciated at month 8. In contrast, the mice
inoculated with PBS did not show any clinical signs, or gross
lesions at necropsy at month 8.
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Recovery of H. pylori by culture
For assessment of colonization by H. pylori, three inoculated
mice underwent necropsy at month 2, and gastric tissues
were obtained for H. pylori culture. H. pylori was isolated
from these three mice, thus demonstrating successful coloni-
zation. At month 8 after infection, H. pylori was isolated from
the stomachs of eight of the remaining 15 mice, but was not
recovered from blood, liver, or gall bladder (Table 2). In
control mice inoculated with PBS, H. pylori was never recov-
ered from stomach, blood, or liver (p <0.01).
Histopathology
All 15 C57BL/6 mice infected with H. pylori for 8 months
developed moderate to severe gastric mucosal inﬂamma-
tion. Two mice developed macroscopic ulceration of the
gastric mucosa. Six of the 15 mice showed gastric atrophy
with mucosal cell proliferation and squamous
transformation (Fig. 1). No lymphoma was observed in
these areas.
Three mice inoculated with H. pylori showed mild to mod-
erate mutifocal hepatitis in parenchymal, perivenular or peri-
portal areas. The lesions consisted of multifocal or
coalescing coagulative necrosis of hepatocytes with inﬂamma-
tory cell inﬁltration at the periphery. The necrotic foci
involved a few or many hepatocytes, and the inﬂammatory
cells were mainly lymphocytes and neutrophils. The punctate
lesions were often adjacent or in close proximity to central
veins and/or intralobular venules. Ballooning degeneration
TABLE 2. Liver and gastric pathology and Helicobacter pylori culture, immunohistochemical staining for H. pylori and
Helicobacter PCR results in stomach, blood, bile and liver samples
H. pylori culture H. pylori staining Helicobacter PCR results
Mouse Gastric pathology Liver pathology Stomach Blood Bile Liver Stomach Gall bladder Liver Stomach Blood Bile Liver
1 Gastritis Normal + ) ) ) + ) ) + ) ) )
2 Gastritis and gastric atrophy Normal ) ) ) ) + + ) + ) + +
3 Gastritis and ulceration Mutifocal hepatitis,
ballooning degeneration
+ ) ) ) + + + + + + +
4 Gastritis Normal + ) ) ) + ) ) + ) ) )
5 Gastritis Normal ) ) ) ) ) ) ) ) ) ) )
6 Gastritis Normal + ) ) ) + ) ) + ) ) )
7 Gastritis and gastric atrophy Normal ) ) ) ) + + + + ) + +
8 Gastritis and gastric atrophy Mutifocal hepatitis,
ballooning degeneration
+ ) ) ) + + + + ) + +
9 Gastritis Normal ) ) ) ) + ) ) + ) )
10 Gastritis and ulceration Normal + ) ) ) + + ) + + + +
11 Gastritis and gastric atrophy Mutifocal hepatitis + ) ) ) + + + + ) + +
12 Gastritis Normal + ) ) ) + ) ) + ) ) )
13 Gastritis and gastric atrophy Normal ) ) ) ) ) ) ) + ) ) )
14 Gastritis and gastric atrophy Normal ) ) ) ) + ) ) + ) ) )
15 Gastritis Normal ) ) ) ) + ) ) + ) ) )
According to the results of H. pylori culturing, staining, and PCR, 14 of 15 inoculated mice showed colonization by H. pylori of the gastric mucosa. H. pylori DNA was detected
in six liver samples from these 14 infected mice. The gall bladder and bile from the above six mice were also positive for H. pylori staining and gene ampliﬁcation. Two blood
samples from these mice were positive for H. pylori genes. These results showed good correlation between the detection methods.
TABLE 1. Oligonucleotide primers used to amplify the 16S rRNA and Helicobacter pylori-speciﬁc genes
Gene Sequence (5¢–3¢) Cycle Amplicon
16S rRNA
First pair of primers GCTATGACGGGTATCC
ACTTCACCCCAGTCGCTG
94C for 1 min, 50C for 1 min, 72C for 1 min, 35 cycles 1200 bp
Nested primers GACACGGTCCAGACTCCTA
TGGCTGATTTGCGATTA
94C for 1 min, 52C for 1.5 min, 72C for 2 min, 30 cycles 1020 bp
26 kDa
First pair of primers TGGCGTGTCTATTGACAGCGAGC
CCTGCTGGGCATACTTCACCATG
94C for 30 s, 68C for 30 s, 72C for 1 min, 35 cycles 298 bp
Nested primers GTCTTTCCCTATGGTGGC
GCATTTCATCTGCATTCCT
94C for 30 s, 55C for 30 s, 72C for 1 min, 30 cycles 167 bp
cagA
First pair of primers ACGATTGGAACGCCACC
CGCCATTTGTAACGCCTA
94C for 1 min, 52C for 1 min, 72C for 1 min, 35 cycles 588 bp
Nested primers ATAATGCTAAATTAGACAACTTGAGCGA
TTAGAATAATCAACAAACATCACGCCAT
94C for 1 min, 52C for 1 min, 72C for 1 min, 30 cycles 297 bp
vacA
First pair of primers GCCCCAGGAAACATTG
ACACCAGCCTTAAACTCAA
94C for 1 min, 50C for 1 min, 72C for 1 min, 35 cycles 617 bp
Nested primers GCCCCAGGAAACATTG
CATAACTAGCGCCTTGCAC
94C for 1 min, 52C for 1 min, 72C for 1 min, 30 cycles 352 bp
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was also observed in some hepatocytes (Table 2, Fig. 2). The
gall bladder mucosa of one H. pylori-infected mouse showed
thickening of the mucous membrane with mild submucosal
lymphocytic inﬁltration (Fig. 3).
In the control mice inoculated with PBS, only slight
increases in lymphoplasmocytic cells were noted in the
stroma of three mice, and no signiﬁcant lesions were
observed in gall bladder or liver tissue (p <0.05).
(a) (b)
(d)(c)
FIG. 1. Gastric inﬂammation associated with
Helicobacter pylori infection (haematoxylin and
eosin staining). (a) Normal gastric musoca of
uninfected animal. (b–d) Signiﬁcant widespread
lymphoplasmacytic gastritis of the entire muc-
osa and parts of the submucosa in the SS1-inf-
ected C57BL/6 mice. Original magniﬁcations:
·300 (a, b) and ·600 (c, d). Arrows indicate
inﬁltrating inﬂammatory cells in the mucosa
and submucosal regions.
(a) (b)
(d)(c)
(e)
FIG. 2. C57BL/6 mouse liver tissue (haemat-
oxylin and eosin, ·300). (a) Focal hepatocyte
necrosis with abundant lymphocyte, macro-
phage and neutrophil inﬁltration around the
central vein. (b) Focal parenchymal inﬂamma-
tion with moderate lymphocyte and neutrophil
inﬁltration and hepatocellular necrosis. (c)
Mild inﬂammatory cell inﬁltration in periportal
and perivenous areas. (d) Ballooning degenera-
tion of hepatocytes. (e) Normal liver tissue of
uninfected mice.
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Immunohistochemical staining and carbol fuchsin staining
for H. pylori in stomach, liver, and gall bladder
Immunohistochemical staining and carbol fuchsin staining for
H. pylori revealed many helical bacteria in the gastric mucosa of
13 of 15 mice inoculated with H. pylori. H. pylori was also pres-
ent in the liver tissues of four mice, often localized between
hepatocytes and in lobular central veins (Fig. 4). Spheroid or
bacilliform H. pylori organisms were also seen in the gall blad-
der mucosa of six of 15 H. pylori-infected mice. No bacteria
were found in these tissues in the control group (p <0.01).
PCR ampliﬁcation for the H. pylori 16S rRNA, 26-kDa, cagA
and vacA genes
H. pylori DNA was detected in 14 of 15 gastric samples from
mice inoculated with H. pylori by nested PCR using speciﬁc
16S rRNA primers. The 26-kDa, cagA and vacA genes were
also detected in these 14 samples, which conﬁrmed coloniza-
tion by H. pylori of the gastric mucosa. Taking together the
results of H. pylori culturing, staining and PCR, the coloniza-
tion rate was 93.3%. The four above-mentioned genes were
also detected in six liver samples of infected mice. Six sam-
ples of bile and two blood samples from mice inoculated
with H. pylori were also positive for the 16S rRNA, 26-kDa,
cagA and vacA genes (Table 2). No Helicobacter genes were
detected in the control group (p <0.01).
Discussion
It has been reported that some Helicobacter spp. (e.g.
H. pylori, H. pullorum, H. bilis, and Helicobacter sp. ﬂexispira)
may be present in intrahepatic or extrahepatic bile ducts in
humans. Helicobacter DNA (including H. pylori DNA) has also
been reported in the liver of patients with HCC in several
studies from various geographical locations [6–8,14], and this
raises the possibility that Helicobacter infection may contrib-
ute to the pathogenesis of HCC. In our previous study, we
also found that Helicobacter DNA was present in samples
from liver with HCC. DNA sequencing and speciﬁc gene
detection showed that the Helicobacter sp. was H. pylori
[10,11]. These reports have suggested that Helicobacter
organisms, including H. pylori, may colonize the liver and pos-
sibly play a pathogenic role in the development of hepatobil-
iary disease in humans.
The presence of H. pylori in the liver tissues of patients
may be explained in two possible ways. It may be a conse-
quence of hepatobiliary disease or, alternatively, H. pylori may
be involved in the genesis of hepatobiliary disease in humans.
In the present investigation, H. pylori DNA was detected in
six liver samples from mice inoculated with H. pylori orally.
Carbol fuchsin staining and immunohistochemical staining
also revealed morphological evidence of H. pylori in four of
six liver tissue samples positive for H. pylori DNA. Three
mice inoculated with H. pylori showed slight to moderate
mutifocal hepatitis in parenchymal, perivenular and periportal
areas, with predominantly lymphocytic inﬁltration, and these
changes are analogous to H. pylori-induced lymphoepithelial
lesions in chronic gastritis or gastric mucosa-associated lym-
phoid tissue lymphoma [15]. These results suggest that
H. pylori can not only spread to the liver in C57BL/6 mice
colonized with H. pylori by oral inoculation, but also cause
pathological changes in the liver. Unfortunately, H. pylori was
(a) (b)
FIG. 3. Gall bladder mucosa of a Helicobacter
pylori-infected C57BL/6 mouse (·300). (a)
Normal gall bladder mucosa. (b) Thickening of
mucous membrane with mild submucosal
lymphocytic inﬁltration.
(a) (b)
FIG. 4. Helicobacter pylori staining in liver tis-
sue of a C57BL/6 mouse (·600). (a) Carbol
fuchsin staining. (b) Immunohistopathological
staining.
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not isolated by culture from the livers of mice in this study,
just as it could not be isolated from the liver samples of
patients with HCC. The reasons are not clear, as we have
discussed in our previous study [10]. Increasing the number
of sites in the liver that are sampled may increase the posi-
tivity rate for H. pylori culture. The organism, however, was
more consistently shown to be present in the livers of the
H. pylori-infected mice by PCR analysis and immunohisto-
chemical staining.
It is not known how H. pylori causes inﬂammation or
necrosis in the liver. The importance of bipolar ﬂagella
and urease in colonization of gastric mucus by H. pylori
has been demonstrated in vivo by studies using isogenic
mutants lacking ﬂagella or this enzyme [16,17]. It will be
interesting to ascertain whether these phenotypic features
of motility and urease activity in H. pylori are also required
for the organism to colonize and persist in livers of mice.
Urease produces ammonia as a byproduct of urea metabo-
lism, and large amounts of ammonia could cause tissue
damage, activate neutrophils, and generate inﬂammatory
cytokines [18,19]. In addition, H. pylori produces a hepato-
cytotoxin in vitro, and this protein may play a role in tis-
sue damage in vivo [14,20].
Studies have shown that mice inoculated intraperitoneally
with H. pylori develop acute hepatitis [21]. We established
the mouse model of H. pylori infection by inoculating orally
instead of intraperitoneally, as the usual route of H. pylori
infection is faecal–oral. Our study showed that the mice
inoculated orally with H. pylori also developed hepatitis. We
may ask by which route H. pylori can spread to the liver. In
our previous study, we found H. pylori DNA in the peripheral
blood of patients with duodenal ulcers infected with H. pylori.
In the present study, H. pylori DNA was detected in two
blood samples [22], which suggested that H. pylori may
spread to the liver by the blood-borne route. Several factors
are known to lead to increased translocation of microbes
across the gastrointestinal barrier. These include disruption
of the ecology of the indigenous gastrointestinal microﬂora
leading to bacterial overgrowth, impaired host immunity, and
physical disruption of the intestinal mucosal barrier by direct
chemical injury, endotoxin, or haemorrhagic shock [23].
H. pylori infection can decrease gastric mucin synthesis, pro-
duce a striking inﬂammatory response, affect microcirculato-
ry variables such as blood ﬂow and leukocyte activity, and
induce changes in the endothelial lining of the vessels them-
selves. These effects may impair the gastric mucosal barrier
and contribute to mucosal injury, leading to H. pylori invad-
ing the bloodstream [24,25]. H. pylori was not cultured from
blood in this study. It may be that H. pylori was present at
levels below that required for successful culture. Some
research groups have reported that Helicobacter spp., includ-
ing H. pylori, can be identiﬁed in bile or gall bladder tissue in
patients with hepatobiliary diseases [26–28]. We also
detected H. pylori DNA in six bile samples from mice inocu-
lated with H. pylori. We postulate that it is possible for
H. pylori to invade the liver and gall bladder via the bile duct.
In our study, no pathological changes of HCC were found
in liver tissue. Wang et al. [29] reported that one C57BL/6
mouse infected with H. pylori strain 119p developed HCC
after 23 months. Further longitudinal studies are warranted
to determine whether H. pylori infections are involved in the
development of HCC.
In conclusion, this study showed that H. pylori inoculated
orally mainly inhabited the gastric mucosa and caused inﬂam-
mation or ulceration at this site, but some H. pylori organisms
could reach the hepatobiliary system and cause inﬂammation
as an independent aetiological factor. Although only three
mice out of 15 showed mild to moderate mutifocal hepatitis,
the results suggested that H. pylori may play a role in such
conditions. Longitudinal studies in a larger number of mice
should be performed to conﬁrm the results.
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